QPS (Austria)

Recent papers from QPS (Austria)

1. Exploration of structural optic nerve changes in mouse models of retinal and neuronal degeneration with optical coherence tomographyBiomedical Optics Express · 2026
2. Towards safe and sustainable ionic liquids: a critical outlook on industrial and pharmaceutical integrationGreen Chemistry · 2026
3. The effect of CysLTR1 inhibition on cells of the retinal neurovascular unit in 5xFAD Alzheimer miceExperimental Eye Research · 2025
4. Comparative Investigation of the Retinal Phenotype of Three Mouse Models of Alzheimer's Disease With Optical Coherence TomographyInvestigative Ophthalmology & Visual Science · 2025
5. Longitudinal investigation of spatial memory and retinal parameters in a 5xFAD model of Alzheimer’s disease reveals differences dependent on genotype and sexBiomedical Optics Express · 2025
6. Montelukast alleviates neuroinflammation and improves motor functions in the line 61 model of Parkinson's disease: An exploratory studyNeurotherapeutics · 2025
7. Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s diseaseTranslational Neurodegeneration · 2025
8. Longitudinal investigation of spatial memory and retinal parameters in a 5xFAD model of Alzheimer’s disease reveals differences dependent on genotype and sex2025
9. Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG miceMolecular Metabolism · 2024
10. Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer’s disease-related blood brain barrier dysfunction and inflammationBrain Research · 2023
11. Evaluating the effect of R-Baclofen and LP-211 on autistic behavior of the BTBR and Fmr1-KO mouse modelsFrontiers in Neuroscience · 2023
12. Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s diseaseMolecular Psychiatry · 2022
13. Exploring Combination Therapies in AD: Additive Effects of the QPCT Inhibitor Varoglutamstat and Aducanumab on Aβ Pathology and Biomarkers In VivoAlzheimer s & Dementia · 2022
14. Application Areas of Ionic Hydraulic FluidsChemical Engineering & Technology · 2022
15. No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines studyBrain Communications · 2022
16. Leukotriene Signaling as a Target in α-SynucleinopathiesBiomolecules · 2022
17. Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol AccumulationInternational Journal of Molecular Sciences · 2021
18. A brain proteomic signature of incipient Alzheimer’s disease in youngAPOEε4 carriers identifies novel drug targetsScience Advances · 2021
19. Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labelingAlzheimer s Research & Therapy · 2021
20. CD4 ⁺ T cells contribute to neurodegeneration in Lewy body dementiaScience · 2021